US, EU Regulators Ban GSK's Avandia In Most Cases
Drug regulators in the U.S. and Europe said Thursday that they would drastically restrict availability of GlaxoSmithKline PLC's diabetes medication Avandia in response to evidence that the drug could cause heart...To view the full article, register now.
Already a subscriber? Click here to view full article